BlackRock, Inc. 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BlackRock Inc. BLK |
12,954,314 7.900% |
6,378,368 (+97.00%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BlackRock Inc. BLK |
6,575,946 7.400% |
1,100,727 (+20.10%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BlackRock Inc. BLK |
5,475,219 7.400% |
1,963,132 (+55.90%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BlackRock Inc. BLK |
3,512,087 5.300% |
3,512,087 (New Position) |
Filing |